Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
Abstract Background Visceral leishmaniasis (VL) is an infectious disease with a variety of clinical signs. The main form of parasite transmission to humans and other mammalian hosts is through the bite of infected arthropod females with Lutzomyia longipalpis serving as the main vector in the America...
Main Authors: | Fabio dos Santos Nogueira, Valdir Carlos Avino, Fredy Galvis-Ovallos, Vera Lucia Pereira-Chioccola, Marcio Antonio Batistella Moreira, Ana Paula Peres Lopes Romariz, Leticia M. Molla, Ingrid Menz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-019-3323-0 |
Similar Items
-
Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment
by: K Pandey, et al.
Published: (2013-01-01) -
Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013-01-01) -
Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
by: Isabel M. Vincent, et al.
Published: (2015-10-01) -
In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in Brazil
by: Caroline Ricce Espada, et al.
Published: (2021-06-01) -
Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
by: Lieselotte Van Bockstal, et al.
Published: (2020-08-01)